Asset Dedication, LLC Editas Medicine, Inc. Transaction History

Asset Dedication, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 28, 2021	SELL	$27.07 - $84.35 $81,210 - $253,049	-3,000 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$18.19 - $31.79 $27,285 - $47,685	-1,500 Reduced 33.33%	3,000 $68,000
Q2 2018 Aug 13, 2018	BUY	$31.4 - $41.01 $138,160 - $180,444	4,400 Added 4400.0%	4,500 $161,000
Q1 2018 Apr 19, 2018	BUY	$29.84 - $44.08 $2,984 - $4,408	100 New	100 $3,000

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Asset Dedication, LLC, based on Form 13F filings with the SEC.

Stay updated on Asset Dedication, LLC with notifications on news.